leisure time -WSS

leisure time

author：fashion 2025-09-29 22:50:06 - browse：9

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Medicare inequities exacerbate Puerto Rico’s health disparities

hotspot

knowledge

WSS

Just how do doctors, lawmakers, and the public define abortion?

Community Health Systems hospitals under DOJ investigation

NEJM study link tiny plastics in blood vessels to heart problems

Amylyx ALS drug fails large clinical trial

The problem with charging patients to message their doctors

Former medical device CEO who sold dummy, plastic parts convicted of fraud

entertainment

leisure time

entertainment

Sports medicine is finally prioritizing gender equality

How to bring more disabled researchers into academia

Medicare proposal to cover medical devices draws a mixed reaction

Sen. Paul opposes bill to ban Chinese biotechs

Guidelines to prevent youth baseball injuries need more muscle

A solution to the after

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

He's a Nobel laureate. Critics say he was misleading on Covid

Wildfire smoke exposes gaps in outdoor worker protections

Antivenom research: Lessons from HIV applied in search for universal antidote

focus

Medicare inequities exacerbate Puerto Rico’s health disparities

In his State of the Union, Biden takes clear aim at 'Big Pharma'

Community Health Systems hospitals under DOJ investigation

NIH study of ME/CFS points to clear biological hallmarks

RSV shot was 90% effective at preventing hospitalizations in kids

Precocious puberty in girls comes with mental health risks

knowledge

hotspot

knowledge

hotspot